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SUMMARY 
The role of the class IIa bacteriocin membrane receptor protein remains unclear and two different 
mechanisms have been proposed: the bacteriocin could interact with the receptor changing it to an 
open conformation or the receptor might act as an anchor allowing subsequent bacteriocin insertion 
and membrane disruption. Bacteriocin-producing cells synthesize an immunity protein that forms an 
inactive bacteriocin-receptor-immunity complex. To better understand the molecular mechanism of 
enterocin CRL35, the peptide was expressed as the suicidal probe EtpM-enterocin CRL35 in 
Escherichia coli, a naturally insensitive microorganism since it does not express the receptor. When 
the bacteriocin is anchored to the periplasmic face of the plasma membrane through the bitopic 
membrane protein, EtpM, E. coli cells depolarize and die. Moreover, co-expression of the immunity 
protein prevents the deleterious effect of EtpM-enterocin CRL35. The binding and anchoring of the 
bacteriocin to the membrane has demonstrated to be a sufficient condition for its membrane insertion. 
The final step of membrane disruption by EtpM-enterocin CRL35 is independent from the receptor, 
which means that the mannose PTS might not be involved in the pore structure. In addition, the 
immunity protein can protect even in the absence of the receptor.  
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INTRODUCTION 
Class IIa bacteriocins, known as pediocin-like bacteriocins, are linear polypeptides with potent 
antilisterial activity, capable of killing target bacteria at concentrations in the sub-nanomolar range 
(Drider et al., 2006). Since they are produced by lactic acid bacteria (LAB), these peptides have 
potential as antimicrobial agents in food. The successful use of pediocin PA-1 as biopreservative in 
the food industry has fostered the research on the mechanism of action of bacteriocins belonging to 
class IIa (Rodríguez et al., 2002). In particular, enterocin CRL35 is produced by Enterococcus 
mundtii CRL35 (Farías et al., 1996; Saavedra et al., 2004) and displays a potent antilisterial activity. 
It seems to be clear at present that class IIa bacteriocins are essentially membrane-active peptides 
(Bruno and Montville, 1993). In fact, these peptides induce the leakage of potassium and phosphate 
ions as well as amino acids and other essential molecules. As a consequence, both components of the 
proton-motive force, ∆ψ and ∆pH, are dissipated and intracellular ATP is thus depleted (Bhunia et al., 
1991; Chikindas et al., 1993). At first, class IIa bacteriocins were believed to interact through their 
positively charged amino acids with anionic phospholipids of the target bacterial cell. Then, an 
amphipathic portion of the bacteriocin would be inserted disturbing the membrane (Drider et al., 
2006). All pediocin-like bacteriocins have a very narrow spectrum of action, which is restricted to 
bacterial genera phylogenetically related to the bacteriocin producer strain. In 2001, Dalet et al. 
described that sensitivity to class IIa bacteriocins from LAB was associated with the mannose 
phosphotransferase system (man-PTS) expression in Listeria monocytogenes (Dalet et al., 2001). 
Thereupon, the man-PTS complex was confirmed as the membrane specific receptor for many class II 
bacteriocins (Ramnath et al., 2004). A phylogenetic analysis of 86 members of the man-PTSs family 
from a wide range of bacterial genera, groups the man-PTSs into three main clusters (groups I, II and 
III). Only members from group I could serve as receptors for class IIa bacteriocins, and the receptor 
efficiency varies in a pattern directly related to their phylogenetic positions (Kjos et al., 2009). For 
that particular reason and because they are unable to cross the outer membrane, bacteriocins do not act 
on Gram-negative bacteria (Chalón et al., 2012). It is currently unclear how these bacteriocins 
permeabilize the membranes of sensitive cells and what the exact role of the receptor is in this 
process. Two possible mechanisms were proposed (Cotter et al., 2005; Kjos et al., 2011): i) the 
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bacteriocin could induce a conformational change in the receptor that would lead to the opening of an 
intrinsic pore; or ii) the bacteriocin could employ the receptor as an anchor to bring the peptide closer 
to plasma membrane, allowing subsequent bacteriocin oligomerization and membrane insertion. The 
amphipathic C- terminal would insert into the membrane, leading to the pore formation. 
An immunity protein encoded by the genetic systems of bacteriocins protects the producer strain 
against its own bacteriocin. There is a variation in the degree of sequence identity among the 
pediocin-like immunity proteins (Fimland et al., 2002). While the N- terminal domain of immunity 
proteins is more conserved, significant differences are observed in the C-terminal region, containing 
several charged residues that are crucial for the specific recognition of cognate bacteriocins (Johnsen 
et al., 2005). A decade ago, it was suggested that the immunity protein formed a strong ternary 
complex with the receptor protein and cognate bacteriocin, thereby preventing cells from being killed 
(Diep et al., 2007). Experimental evidence suggests that the immunity protein-man-PTS complex only 
occurs in the presence of the extracellular bacteriocin. Thus, the immunity protein would not act by 
preventing the binding of the bacteriocin to its receptor, but rather by direct interaction with the man-
PTS-bacteriocin complex. Therefore, it might block the process that leads to membrane 
permeabilization and cell death. These observations strongly support the first mechanism commented 
above, and became the generally accepted paradigm of the mechanism of action and immunity of 
class IIa bacteriocins. However, neither the stoichiometry of the ternary complex nor the way in 
which the proteins interact with each other is known. 
The design of a suicide genetic construct, which expresses a chimeric protein EtpM-microcin V has 
previously been reported (Gérard et al., 2004). EtpM is a bitopic membrane protein belonging to the 
Type II secretion system (SstII) from enterohemorrhagic Escherichia coli serotype O157:H7 (Lim et 
al., 2007), and microcin V (MccV, or colicin V) is a linear non-modified class IIa microcin secreted 
by E. coli (Gratia, 1925). MccV alters the permeability of the membrane requiring the membrane 
protein SdaC as a receptor (Yang and Konisky, 1984; Rodríguez and Laviña, 2003; Gérard et al., 
2005; Biéler et al., 2010). The 5' of the MccV structural gene cvaC, was fused with the 3' of truncated 
etpM under the control of the PBAD promoter. When the expression of etpM-cvaC chimeric gene is 
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induced with arabinose, MccV is translocated to the periplasm but remains anchored in the inner 
membrane through EtpM. The bacteria expressing the chimeric gene die; hence the fusion protein is 
called "suicide probe". Interestingly, the co-expression of the immunity protein of MccV completely 
protects the host cell from the lethal effect of the suicide probe EtpM-MccV (Gerard et al., 2004; 
Gérard et al., 2005).  
A complete understanding of the mechanism of membrane insertion of bacteriocins and microcins is 
crucial for the design and construction of new bacteriocins improved by genetic engineering (Acuña 
et al., 2012). In this regard, several questions arise such as: can a class IIa bacteriocin from Gram-
positive bacteria be active in Gram-negative bacteria? Is the presence of the membrane receptor in 
target cells the unique requirement for the bacteriocin mechanism of action? To answer these 
questions, we built a chimeric peptide (EtpM-Ent35) by fusing etpM with the structural gene of the 
class IIa bacteriocin, enterocin CRL35. Our results suggest that enterocin CRL35 fused with EtpM 
can form pores in the absence of the man-PTS complex in E. coli membrane. Therefore, the receptor 
would work just as an anchor on the target cell membrane. Furthermore we show that the immunity 
protein of enterocin CRL35 co-expressed with EtpM-Ent35 in E. coli is able to counteract the 
bactericidal effect of the suicide probe, even in the absence of its specific receptor.  
EXPERIMENTAL PROCEDURES 
Bacterial culture media and growth conditions- Bacteria and plasmids used are listed in Table 1. 
Primer sequences are listed in Table 2. Luria broth (LB) and TSB were purchased from Sigma 
Chemical Co (St. Louis, MO) and Britania, respectively. Enterococcus mundtii CRL35 was grown in 
LAPTg medium (g. L
-1
: 15, peptone; 10, tryptone; 10, glucose; 10, yeast extract; 1, Tween 80). Solid 
media were prepared by adding agar to a final concentration of 1.5%. When required, 50 µg mL
-1
 
ampicillin, 30 µg mL-1 chloramphenicol, glucose 0.6%, lactose 0.2% and arabinose 0.2% or 0.6% 
were added. 
Genetic constructions, cloning and cell transformation- The plasmid p1707 was a gift from Dr. 
Emilse Masias (INSIBIO, CONICET-UNT). It encodes for enterocin CRL35 structural gene munA, 
which is preceded by a twin arginine translocation (Tat) signal that leads the peptide to the periplasm, 
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under the tight control of PBAD promoter. The resulting peptide was called RR-Ent35 and its signal 
sequence is supposed to be removed by a membrane associated proteolytic enzyme after translocation 
to the periplasmic side (Palmer and Berks, 2012).  
To obtain the suicide probe EtpM-Ent35, we replaced the sequence that encodes the Tat signal in 
p1707 with a truncated etpM gene (etpM49) (Gerard et al., 2004), obtaining etpM49-munA under the 
control of PBAD. The etpM49 fraction was amplified from the strain E. coli O157:H7 by colony PCR, 
using primers etpmcor and etpmnh1 as forward and reverse, respectively (Gerard et al., 2004). The 
amplified fragment was purified, digested with EcoRI and NheI. E. coli DH5α was transformed with 
the ligation mixture containing DNA ligase (New England Biolabs
®
), and both digested p1707 and 
etpM49. Transformed cells were plated onto LB ampicillin agar added with 0.6% glucose. Yielded 
colonies were streaked on LB plates containing arabinose 0.6% or glucose 0.6%. If the suicidal probe 
was correctly expressed, the cell would die in presence of arabinose. Hence, one colony which was 
unable to grow in the presence of arabinose was selected from the glucose supplemented plate to 
purify the plasmid named p-etpM-munA. The resulting construction codifies a chimeric protein 
EtpM1-49-enterocin CRL35 (EtpM-Ent35) where EtpM1-49 is a truncated version of EtpM but still 
contains the transmembrane segment. 
In order to express the control protein EtpM, the complete etpM gene was amplified; the PCR product 
was digested with EcoRI and HindIII and then was ligated into p8760 vector (Guzman et al., 1995). 
The resulting plasmid was called p-etpM. 
The immunity gen, munC, was amplified from pE35 (Saavedra et al., 2004) by PCR using the 
following primers: munCrXhoI and munCfNdeI. The amplified fragment were digested by XhoI and 
NdeI and cloned into the plasmid pACYCDuet-1 (Novagen). Therefore, immunity protein from 
enterocin CRL35 were under control of lac-promoter. 
All the genetic constructions were confirmed by DNA sequencing (CERELA, CCT-Tucumán). E. coli 
BL21 strain (Novagen) was transformed with the plasmids described above by the classical calcium 
chloride transformation protocol(Sambrook and Russell, 2001).  
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Antimicrobial activity of EtpM-Ent35- All strains described in the present work were grown in LB - 
glucose 0.6% at 37°C until exponential phase (OD600 ~ 0.6). Cells were collected by centrifugation, 
washed and resuspended in LB. The expression of the immunity protein was induced with lactose 
0.02% for 1 hour and the fusion EtpM-Ent35 with arabinose 0.6 % for 5 minutes. Cells were 
centrifuged and resuspended in 20 mM Tris-HCl, 0.2% Triton X-100 pH 7.4. Then, cells were 
sonicated in an ice bath for 10 min. 10 μl of each cellular extract was spotted onto TSB or LAPTg 
agar plates. After the drops had dried, the plates were layered with 4 ml of 0.6% agar containing 10
7
 
cells of L. innocua 7. The plates were incubated overnight at 30 °C and examined for growth 
inhibition. When the antimicrobial activity was assayed against E. coli BL21, LB plates were 
employed and cells were grown at 37ºC overnight. 
Subcellular fractionation. The bacterial strains were grown until OD600 = 0.6. At that point they were 
induced with 0.6% arabinose for 10 minutes at 37°C and the cultures were divided in two. Each half 
was centrifuged at 7600 x g for 2 minutes, the supernatant was saved and the pellet was resuspended 
in 100 mM Tris-HCl, 5 mM EDTA, pH 7.5. EDTA acts as an OM perturbing agent (Gray and 
Wilkinson, 1965). One of the samples was supplemented with protease inhibitor cocktail (Sigma 
®
) + 
PMSF 1 mM (Sigma ®) and the other with proteinase K (10 µg/ml). Then, cells were centrifuged and 
the supernatants were heated 10 minutes at 65ºC to inactivate proteinase K. This supernatant was 
separated as periplasm fraction. The pellets were washed, resuspended in 100 mM Tris-HCl pH 7.5 
buffer and then cells were disrupted by sonication. After a centrifugation at 50,000 x g for 1 hour, the 
cytoplasm was removed and finally the membrane fraction was resuspended in 100 mM Tris-HCl pH 
7.5 buffer with 0.2% Triton. Finally, the different subcellular fractions of each treatment were spotted 
on TSB agar plate covered with a L. innocua 7 lawn.  
Suicide probe and immunity protein expression- In order to study the effect of the suicide probe 
expression in E. coli cells, we carried out different experiments. In the first one, a semi quantitative 
approach, control cells E. coli BL21 (p-etpM) as well as E. coli BL21 (p-etpM-munA) and E. coli 
BL21 (p-etpM-munA) (pmunC) cells were grown in LB-glucose 0.6% to an OD600 ~ 0.6. The cells 
were then collected by centrifugation and diluted in LB-glucose 0.6% (repressed) or LB-lactose 
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0.02% (immunity induced). 10 μl of repressed cell suspensions were plated on LB agar supplemented 
with glucose 0.6% or L-arabinose 0.6%. In the same way, cells with pre-induced immunity expression 
were plated on LB agar supplemented with lactose 0.02% or lactose 0.02% + L-arabinose 0.6%. The 
plates were incubated overnight at 37 °C. 
For the quantitative approach, all strains were incubated with shaking at 37 °C in LB-glucose 0.6% 
until OD600 ~ 0.3. They were washed and resuspended in LB with lactose 0.02% for 1 hour to induce 
the expression of MunC. The expression of the fusion EtpM-Ent35 was induced upon addition of 
arabinose 0.6% during 5 minutes. After that, cells were washed, and resuspended in 20 mM Tris-HCl 
buffer pH 7.4. Aliquots were log-diluted and plated onto LB medium and colony forming units (CFU) 
were counted after an overnight incubation at 37 °C. 
A bacterial viability test was utilized as a complementary measurement. For that purpose, live/dead 
bacteria were quantified using the LIVE/DEAD® BacLightTM bacterial viability Kit from Invitrogen 
(Life Technologies Corporation). Cells were grown and induced as for CFU counting experiment. 
Aliquots of 1 ml of each cell suspension were centrifuged and resuspended in 20 mM Tris-HCl buffer 
pH 7.4 to obtain an OD600 ~ 0.1. Finally, the fluorophores SYTO 9 and propidium iodide were added 
from a pre-mixed solution and the fluorescence was determined. The excitation wavelength was set at 
488 nm and emission was adjusted to 500 nm for SYTO 9 and 617 nm for propidium iodide. The 
samples were also observed with an epifluorescence microscope Olympus BX51. For this purpose, a 
number of fields were randomly selected for each sample, and cells were observed with a 100X 
objective lens and a numerical aperture of 1.4. The CFU/ml were determined before and after the 
induction of the suicide probe. Logarithmic dilutions of the cultures were made and spots were placed 
on LB plates. 
Tricine SDS-PAGE: Electrophoresis were carried-out as previously described (Schägger, 2006) and 
the samples were treated with loading buffer without β-mercaptoethanol. For fusion protein activity 
the gel was fixed, and then washed successively with ethanol 70%, 30% and sterile bidistilled water. 
The gel was placed on TSB agar plate, covered with 10 ml of 0.6% (w/v) agar inoculated with 10
6
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cells of L. innocua 7 (Acuña et al., 2012). The plate was incubated at 30 °C for 16 h and the inhibition 
zones were examined.  
For immunity protein expression analysis, E. coli BL21 (pACyC-Duet) and E. coli BL21 (p-munC) 
strains were grown until OD600~0.6, then induced with 0.01 mM IPTG or repressed with 0.6% 
glucose. A milliliter of each culture was centrifuged, washed, resuspended in loading buffer with β-
mercaptoethanol and then boiled for 5 minutes. The expression of MunC immunity protein was 
further confirmed by Tris-Tricine SDS-PAGE electrophoresis revealed with Coomassie Blue. In 
Figure 1S a band of 11.05 kDa can be observed in lane 5 which corresponds to the calculated size of 
the immunity protein MunC. The band corresponding to MunC protein is not observed on the lane of 
repressed extracts nor the control expressing the empty plasmid. This confirms the correct expression 
of the MunC immunity protein. 
Cell membrane permeabilization measurements- Cytoplasmic membrane permeabilization was 
determined by using the potential sensitive dye 3,3 dipropyl thiacarbocyanine iodide (DiSC3[5]) (Wu 
et al., 1999), purchased from Invitrogen (Life Technologies corporation). The dye concentrates in the 
cytoplasmic membrane of energized cells, resulting in self-quenching of its fluorescence. The control 
cells expressing only EtpM as well as the cells expressing the fusion EtpM-Ent35 and the fusion 
peptide plus the immunity protein MunC were grown in LB medium at 37°C to exponential phase 
(OD600 ~ 0.2). The expression of MunC was induced with lactose 0.02 % for 1 hour. Then cells were 
collected by centrifugation and resuspended in 50 mM HEPES, 5 mM EDTA, pH 7 to obtain an OD600 
~ 0.1. The cell suspension was incubated at 37°C with 0.4 µM DiSC3 [5] until the dye uptake was 
maximal (as indicated by a stable reduction of fluorescence). The expression of the fusion EtpM-
Ent35 was induced with arabinose 0.6%. The emission of fluorescence was monitored at 667 nm as a 
function of time (excitation emission wavelength: 622 nm). 
RESULTS  
Expression of the suicide probe in E. coli 
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In order to evaluate a possible effect of enterocin CRL35 in E. coli, we constructed a suicide probe, 
using EtpM as a membrane anchor for enterocin CRL35 (Gérard et al., 2004). EtpM is a bitopic 
membrane polypeptide of 170 residues. Using the TMHMM server, it is predicted that the first 18 
residues are located in the cytoplasm, the following 23 residues form a transmembrane α-helix and the 
C-terminal 129 residues are located in the periplasm (Krogh et al., 2001). The genetic construction 
was cloned under the PBAD promoter (see experimental procedures). Upon arabinose induction 
(Santini et al., 2001), EtpM is driven to the cell membrane of E. coli and its C-terminus is translocated 
to the periplasm alongside the bacteriocin that was fused to it, in a process mediated by YidC protein 
(Gerard et al., 2004). Thus, the bacteriocin remains anchored to the cell membrane by EtpM on the 
periplasmic side. If the expression of the suicide probe turns out to be lethal to the host cell, it would 
indicate that the bacteriocin could be inserted into the inner membrane.  
To select a colony with a correctly cloned suicide construction, twenty colonies obtained from the 
transformation plate were picked and streaked on LB supplemented with glucose 0.6% (repressed) or 
arabinose 0.6% (induced). Most of the clones do not grow in the presence of arabinose (Figure 1A). 
One of them was selected to purify the plasmid p-etpM-munA. This preliminary experiment proves 
that the synthesis of the chimera EtpM-Ent35 is lethal for the host cells. The action of EtpM-Ent35 in 
E. coli, even in the absence of a specific receptor, suggests that enterocin CRL35 would only require 
to be brought to the membrane surroundings in order to exert its activity. 
Anti-Listeria activity of EtpM-Ent35 fusion  
To check whether the suicide probe possess antimicrobial activity by itself, the cellular extracts of 
different E. coli strains expressing EtpM, EtpM-Ent35, RR-Ent35 and co-expressing EtpM-Ent35 and 
MunC were assayed against L. innocua 7 and E. coli BL21. It is observed that the cell extracts from E. 
coli BL21 p-etpM-munA, E. coli BL21 p1707 and cells co-expressing the toxic fusion and the 
immunity protein show inhibition halos against L. innocua 7. In contrast, the cellular extract obtained 
from the control strain, which expresses EtpM does not show antimicrobial activity (Figure 1B). 
These results indicate that the addition of EtpM at the N-terminus of enterocin CRL35 does not affect 
the antimicrobial activity of the bacteriocin. When the antimicrobial activity against E. coli is assayed, 
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no inhibition halo is observed. As we show below, if enterocin CRL35 is not anchored in the 
membrane, it cannot affect E. coli. 
To confirm the expression of the suicide probe we carried out a Tris-Tricine SDS-PAGE. 
Electrophoretic comparison of synthetic enterocin CRL35 and the membrane fraction from strains E. 
coli BL21 (p-etpM-munA) and BL21 (p-etpM-munA) (p-munC) are shown in Figure 2A. Two bands 
with antimicrobial activity against L. innocua 7 are observed (lanes 1 and 2). It is possible that a 
proteolytic cleavage of EtpM-Ent35 occurs, resulting in a low molecular mass enterocin CRL35 
derivative peptide.  
The EtpM-Ent35 fusion translocates the Ent35 portion to the periplasm 
In order to confirm the location of the suicide probe we compared the antimicrobial activity of 
subcellular fractions of the strain expressing EtpM-Ent35. EDTA permeabilized cells were treated 
with proteinase K or PMSF plus protease inhibitor cocktail as a control. Then the proteinase activity 
was inactivated by heating 10 minutes at 65 ºC, as described in experimental procedures. It was 
previously pointed out that EDTA allows permeabilization of the OM. As a consequence, proteinase 
K would be able to reach the periplasm and inactivate enterocin CRL35 only if EtpM-Ent35 were 
efficiently translocated to the periplasm and the enterocin CRL35 portion were actually placed in the 
periplasmic face of the membrane. Indeed, after the arabinose induction, only the membrane fraction 
has antimicrobial activity confirming that EtpM-Ent35 is in fact bound to the membrane. Besides, 
proteinase K treated samples loses antimicrobial activity (Figure 2B) supporting the concept that 
enterocin CRL35 portion is located towards the periplasm.  
Enterocin CRL35 is not active on E. coli 
It is well established that class IIa bacteriocins produced by LAB cannot pass across the Gram 
negative bacteria outer membrane (OM) and therefore they are not active on E. coli (Stevens et al., 
1991; Chalón et al., 2012). However, it has been suggested that the combination of some pediocin-
like bacteriocins and OM-disrupting agents may be active on Gram-negative bacteria (Naghmouchi et 
al., 2011; Adler et al., 2011). 
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To prove that enterocin CRL35 does not have an IM receptor and is therefore inactive on E. coli, we 
employed the strain E. coli BL21 (p1707) where RR-Ent35 could be exported to the periplasm by the 
TAT secretion system upon the induction with arabinose (see Experimental Procedures). E. coli cells 
carrying the plasmid p1707 grow normally in LB medium, both repressed with glucose 0.6% and 
induced with arabinose 0.6 % (Figure 2S). Moreover, E. coli cells with altered OM by osmotic shock 
are unaffected when the purified enterocin CRL35 is added to the medium (see Supplementary 
Material, Figure 3S). Therefore, we conclude that enterocin CRL35 is not active on E. coli when it is 
delivered to the periplasm in both, inside-out and outside-in ways. These results further confirm that 
there is not a receptor on E. coli IM for enterocin CRL35. It is important to note that RR-Ent35 is in 
fact being expressed by E. coli BL21 since, after the addition of the inducer, samples from culture 
crude extracts display anti-listerial activity (Figure 1B). 
Protective effect of the immunity protein 
If the killing effect of the suicide chimera comes from the bactericidal activity of the bacteriocin, the 
co-expression of the immunity protein should protect the host cells. As it can be observed in Figure 
3A, control cells E. coli BL21 (p-etpM); E. coli BL21 (p-etpM-munA) as well as the strain E. coli 
BL21 (p-etpM-munA) (p-munC) grow normally in LB agar plates supplemented with glucose 0.6%. 
However, the growth of cells expressing the EtpM-Ent35 fusion is significantly affected when they 
are plated onto LB agar containing arabinose, while the control cells are not affected. Moreover, the 
basal production of the immunity protein in the plates supplemented only with arabinose is apparently 
sufficient to observe a protective effect on the strain expressing both the chimera and the immunity 
protein. This could be explained by the well-known "leaky" nature of the lac promoter (Müller et al., 
1996). In fact, CFU are similar in plates supplemented only with arabinose or in arabinose-lactose 
plates. Results show that enterocin CRL35 immunity protein is capable of protecting cells from the 
lethal effect of the suicide probe even in the absence of the specific receptor. This evidence strongly 
supports the notion that the membrane perturbation and the bacterial death induced by the fusion 
peptide is exclusively associated with the bacteriocin part of the chimera. 
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In a quantitate assay, colony forming units were analyzed upon induction of the suicide probe during 
5 minutes with arabinose, as well as the co-expression of the fusion peptide and the immunity protein. 
Figure 3B shows that cell count drops from 5.8 108 to 1 108 which represented an 82.7% decrease in 
viability. This result is backed up by the LIVE/DEAD® BacLight
TM
 bacterial viability Kit (Figure 
3D). Actually, we find 40% viable cell decrease upon induction of the chimera. Interestingly, MunC is 
shown to fully protect cells from the deleterious effect of EtpM-Ent35 by these two different 
approaches. 
Fluorescence microscopy was used to visualize the effect of the different protein expression using 
LIVE/DEAD® BacLightTM. Figure 3E shows E. coli BL21 strains after induction with arabinose, 
which express only EtpM (control), EtpM-Ent35 and both EtpM-Ent35 and MunC. The suicide probe 
expression disturbs the membrane permeability, so bacteria emit red fluorescence (dead cells). As 
regards the immunity protein, the strain co-expressing EtpM-Ent35 and MunC increases the number 
of green cells compared to the strain that only expresses the suicide probe. The assay using 
LIVE/DEAD BacLight kit shows good correlation with the viable CFU count on LB agar plates 
(Figure 3C). 
Effect of the EtpM-Ent35 fusion on E. coli transmembrane potential 
Like other class IIa bacteriocins, enterocin CRL35 dissipates the electric potential (∆ψ) and the proton 
motive force (∆pH) on sensitive cells (Minahk et al., 2000). Therefore, we studied changes in the 
electric potential of E. coli cells upon induction of the fusion peptide using the membrane-potential 
sensitive fluorescent probe DiSC3[5]. After the addition of arabinose, ∆ψ is markedly dissipated in 
cells expressing EtpM-Ent35, showing an increase in the fluorescence signal over time, as it can be 
seen in Figure 4. The cells that co-express both the suicide probe and the immunity protein, show 
much less pronounced transmembrane potential dissipation, probably due to MunC effect, which 
might obliterate the suicidal activity of the fusion. In contrast, no significant changes are observed in 
the fluorescence intensity in control cells that only express the membrane anchor (EtpM). The fact 
that cells expressing MunC undergo some dissipation of the membrane potential without significant 
changes in cell viability is not a contradictory finding. In effect, Masias et al. have reported that 
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∆ψ dissipation is a necessary factor in the enterocin CRL35 mechanism of action but it is not 
sufficient for promoting cell death (Masias et al., 2015). As a matter of fact, ∆ψ changes induced by 
an antimicrobial peptide primarily indicates that the membrane has been targeted and a membrane-
peptide interaction has taken place. The degree of ∆ψ dissipation is a better indication of how 
detrimental this interaction turns out to be. 
DISCUSSION 
The expression of a suicide probe in E. coli, based on the membrane protein EtpM and a bacteriocin 
from a Gram-positive bacterium, reveals new insights into the class IIa bacteriocins mechanism of 
action. Nowadays, it is well established that class II bacteriocins require a receptor in the plasma 
membrane of the target cell to exert their antimicrobial effects (Duquesne et al., 2007; Cotter et al., 
2013) . However, the precise role of the receptor protein and the nature of the pore that is formed are 
still unknown. It is clearly shown that enterocin CRL35 is not able to exert any bactericidal effect on 
E. coli cells when it is expressed and targeted to the periplasm. This result shows that E. coli 
membrane does not possess a receptor for the bacteriocin and, as a consequence, RR-Ent35 does not 
exhibit any antimicrobial activity.  
This fact could be explained mainly by two reasons: on the one hand, bacteriocins belonging to class 
IIa cannot cross the outer membrane, hence they are unable to reach their ultimate target, the plasma 
membrane (Chalón et al., 2012). On the other, Gram-negative bacteria do not express the mannose 
permease belonging to group I, the receptor for class II bacteriocins produced by Gram-positive 
bacteria (Kjos et al., 2009). Moreover, even if some membrane proteins might act as receptors and the 
bacteriocin could cross the OM, bacteriocins may not insert properly into the plasma membrane of 
Gram-negative bacteria because phospholipids are quite different. In fact, membranes of L. 
monocytogenes and LAB mainly contain anionic phospholipids such as phosphatidylglycerol and 
cardiolipin. Phosphatidilethanolamine only represents 8% of total phospholipids (Crandall and 
Montville, 1998). In addition, L. monocytogenes is characterized by branched chain fatty acids 
(Mastronicolis et al., 2005). On the contrary, E. coli plasma membrane contains up to 70% of the 
zwitterionic phospholipid phosphatidylethanolamine and the combination of phosphatidylglycerol and 
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cardiolipin represents just one third of total phospholipids (DeChavigny et al., 1991). As it has been  
demonstrated in this work, the probe disturbs the membrane integrity of Gram-negative bacteria in  
spite of its composition. Thus, enterocin CRL35 has the potential to be employed as a broad range  
food biopreservative if it is properly engineered.   
On the other hand, if the bacteriocin is somehow anchored to the IM, it is able to exert a bactericidal  
effect, suggesting that one of the roles of the receptor might be just as a mere docking molecule,  
bringing closer the bacteriocin to the plasma membrane in order to get the peptide inserted and  
produce cell injury (Figure 5A).  
It has been previously reported that class IIa bacteriocins are able to acquire a structured form if they  
are placed in a phospholipid-like environment such as DPC micelles (Fregeau Gallagher et al., 1997;  
Uteng et al., 2003). Indeed, the bacteriocins hold a random coil conformation in water, but a helical  
structure is induced when they get attached to micelles, which would contribute to the membrane  
permeabilization.   
Based on this former evidence, is logical to think that, when EtpM anchors enterocin CRL35 to the  
periplasmic side of the membrane, the proximity of the peptide to the lipid bilayer would induce a  
conformational change of the bacteriocin that would lead to the formation of a pore, disturbing the  
integrity of the membrane, all in the absence of man-PTS.  
As it was previously mentioned, a bacteriocin producer strain also synthesizes a specific immunity  
protein, named MunC for enterocin CRL35 (Saavedra et al., 2004). Previous reports in literature  
demonstrated that the addition of immunity proteins from class IIa bacteriocins to the extracellular  
medium, does not affect the antimicrobial activities of the corresponding bacteriocins (Nissen-Meyer  
et al., 1993; Quadri et al., 1995). Therefore, it was concluded that bacteriocin-immunity protein  
interaction did not exist or this interaction was weak (Drider et al., 2006). Diep et al. previously  
demonstrated that class II bacteriocins associate with the membrane receptor and the immunity  
protein in a bacteriocin producer strain, forming a ternary complex in which the activity of the  
bacteriocin can be counteracted (Diep et al., 2007). Here we show that the protective effect of the  
immunity protein, MunC, neutralizes EtpM-Ent35 activity and it might block the pore structure in this  
condition. This mechanism occurs in the absence of the membrane receptor, suggesting a direct  
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bacteriocin-immunity protein interaction. Even though Diep’s conclusion is that man-PTS is a 
necessary component for bacteriocins mechanism of action, the fact that the immunity protein acts 
only if the bacteriocin is present, supports this conclusion. We hypothesize that immunity protein 
could recognize and bind class IIa bacteriocins in a membrane-inserted form (Figure 5B and 5C). 
In conclusion, the present paper shows evidence that EtpM-Ent35 might form functional pores on E. 
coli membrane. The fusion peptide is able to dissipate the membrane electric potential once anchored 
to the plasma membrane, in spite of lacking a specific receptor (Figure 5A). We propose a new model 
for enterocin CRL35 mechanism of action and immunity based on experimental evidence (Figure 5B). 
It is possible that class IIa bacteriocins produced by Gram-positive bacteria just need to stablish an 
intimate contact with the target membrane to get inserted. Subsequently, the bacteriocin itself would 
be able to form a pore in the absence of the receptor. Indeed, immunity protein would not require the 
presence of the receptor either in order to recognize the bacteriocin pore and prevent its deleterious 
action. This is the first in vivo evidence indicating that the receptor could not be involved in the pore 
structure but rather it would act as an anchor molecule. This observation has great importance for the 
designing of bacteriocins with biotechnological applications, as food biopreservative or with potential 
use in the pharmaceutical industry. 
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Table 1. Strains and plasmids 
Strain Description Reference 
E. coli DH5α 
F¯ φ80lacZ∆M15 recA1 ∆(lacZYA-argF)U169 endA1 supE44 
hsdR17 (rk¯mk
+) thi-1 gyrA96 relA1 deoR phoA 
 
Promega 
 
E. coli BL21 [DE3] E. coli BF
- ompT hsdS(rB-mB-) gal dcm λ(DE3) Novagen 
E. coli O157:H7  
ATTC 700728 
etpM template ATCC 
Listeria innocua 7 Sensitive to enterocin CRL35 INRA (France) 
Enterococcus mundtii 
CRL35 
Enterocin CRL35 producer strain 
CERELA culture 
collection 
Plasmid Description  Reference 
pACYCDuet-1 
Expression vector, Cmr
 
Novagen® 
p8760 pBAD24 with GFP cloned, Ap
r
 
(Santini et al., 2001) 
p-etpM p8760 with etpM gene cloned and without GFP, Ap
r This work 
pE35 
pCR-Blunt II- Topo (Invitrogen) with enterocin CRL35 
biosynthetic cluster cloned 
 
(Saavedra et al., 2004) 
pmunC pACYCDuet-1 with munC gene cloned,Cm
r
 This work 
p1707 p8760 with munA gene cloned Apr A gift from Masias E.  
p-etpM-munA 
p1707 with etpM gene cloned, Ap
 This work 
Cm
r
, chloramphenicol resistant; Ap
r
, ampicillin resistant. CGSC, E. coli Genetic Stock Center.  553 
INRA: Unité de Recherches Laitiéres et Génetique Appliqueé. ATCC: American Type Culture 554 
Collection. CERELA: Centro de Referencias para Lactobacilos, Tucumán. Argentina. LMGT, 555 
Laboratory of Microbial Gene Technology. FBQF: Facultad de Bioquímica, Química y Farmacia; 556 
Universidad Nacional de Tucumán, Argentina.  557 
  558 
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Table 2. Primers  
Name Sequence 5´- 3´ 
munAFNheI TGGCTAGCAAATACTACGGTAATGGA 
munARHindIII CGAAGCTTTTAACTTTTCCAACCAG 
munCFNdeI GGTGGTCATATGAGTAATTTAAAGTGGTTTTC 
munCRXhoI GGTGGTCTCGAGCTAATATCCATATCTAATATTAG 
etpmcor CCTGAGAATTCACAATGAACGAGCTTAAAA 
etpmnh1 ACTGTGTTTTTTTCACGGCTAGCTACAGTC 
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FIGURE LEGENDS 
FIGURE 1. A) Selection of E. coli DH5α EtpM-Ent35 expressing clones. After transformation 
with the ligation mixture containing the plasmid p1707 and etpM49 digested, twenty colonies were 
plated on LB-glucose 0.6 % (above) or LB- arabinose 0.6 % (below). The plates were incubated at 
37 °C overnight. Control: E. coli DH5α (p1707). B) Antimicrobial activity of probe expressing 
strains. 20 µl of crude extracts obtained after induction with arabinose 0.6 % where spotted and tested 
against of L. innocua 7 (above) and E. coli BL21 (below). EtpM: E. coli BL21 (p-etpM); EtpM-
Ent35: E. coli BL21 (p-etpM-munA); EtpM-Ent35/MunC: E. coli BL21 (p-etpM-munA) (pMunC); 
and RR-EtpM: E. coli BL21 (p1707), respectively.  
FIGURE 2. Expression and cellular localization of EtpM-Ent35. A) Biological activity revealed 
by Tris-Tricine SDS-PAGE.  Membranes were purified by ultracentrifugation and proteins were 
separated by electrophoresis. Fixed gel was placed on TSB and covered with soft agar inoculated with 
L. innocua 7. The picture shows the zones of growth inhibition by the membrane fraction from 
arabinose induced cells. Lane 1: EtpM-Ent35 expressing membranes, lane 2:  EtpM-Ent35/MunC 
expressing membranes and lane 3: synthetic enterocin CRL35 (MM: 4.29 kDa). Calculated molecular 
mass for EtpM-MunA: 10.35 kDa. B) Subcellular localization of EtpM-Ent35 expressed in E. coli 
BL21. A culture of E. coli BL21 expressing EtpM-Ent35 was harvested, washed and permeabilized 
with EDTA. Then it was split and each half was treated with proteinase K (PK) or PMSF plus 
protease inhibitor cocktail, respectively. Then the different subcellular fractions of each treatment 
were obtained and 10 µl of each one were spotted on TSB agar plate and covered with a L. innocua 7 
lawn. 1) supernatant, 2) periplasm, 3) cytoplasm and 4) membrane.  
FIGURE 3. Viability of strains expressing EtpM-Ent35 and immunity protein. The strains E. coli 
BL21 (p-etpM-munA); E. coli BL21 (p-etpM-munA) (pmunC) and control E. coli BL21 (p-etpM) 
were grown in LB-glucose 0.6% until OD600 ~ 0.6. Then they were harvested, washed and 
resuspended in LB. A) Logarithmic dilutions of each culture were made and 10 µl of each dilution 
were spotted on plates with glucose 0.6 %, arabinose 0.6 % or arabinose 0.6 % + lactose 0.02 %. B 
and C) Effect of 5 minutes arabinose induction on cellular viability. Cultures were induced with 
lactose during 1 h and then with arabinose 0.6% for 5 minutes. Cells were washed and resuspended in 
Page 23 of 36 Molecular Microbiology
This article is protected by copyright. All rights reserved.
24 
 
20 mM Tris-HCl buffer pH 7.4. The viability was estimated by CFU/ml counting on LB plates. 
Results are representative of three independent replications. Different letters indicate significant 
differences according to Tukey's test, p <0.0001. D) Quantification by using LIVE/DEAD® 
BacLight
TM
 bacterial viability Kit. Results represent the average of three independent experiments ± 
standard deviations. Different letters indicate significant differences according to Tukey's test, p 
<0.0001. (E) Fluorescence microscopy images of live and dead cells after 5 minutes induction with 
arabinose as described in figure 3B. 
FIGURE 4. Effect of EtpM-Ent35 in cell membrane electric potential. The expression of the 
fusion and the immunity protein was induced with arabinose 0.6 % and lactose 0.02 %, respectively. 
DiSC3[5] was added at a final concentration of 0.4 µM and fluorescence was registered over time. 
Excitation and emission wavelengths were set at 622 and 667 nm respectively. This data is 
representative of three separate studies. 
FIGURE 5. A) Model for expression of EtpM-Ent35 in E. coli. The expression of EtpM-Ent35 
fusion peptide could result in the insertion of enterocin CRL35 in the membrane of E. coli. EtpM is 
translocated and inserted by YidC (Gérard et al., 2004). Once EtpM is anchored in the membrane; 
enterocin CRL35 portion may penetrate from the periplasm and disrupt the membrane. etpM-munA is 
under control of the PBAD promoter, induced by arabinose and repressed by glucose. OM: outer 
membrane, IM: inner membrane, PG: peptidoglycan. B) Model for EtpM-Ent35 and MunC 
mechanism of action in E. coli. The suicide probe EtpM-Ent35 is translocated to E. coli periplasm. 
Then enterocin CRL35 would be inserted in the membrane forming an oligomeric pore. The 
dissipation of the electrochemical gradient and outflow of small organic molecules would trigger the 
cell death. When immunity protein MunC is co-expressed (right panel), it would recognize the 
inserted bacteriocin in the membrane forming a bacteriocin-immunity protein complex preventing cell 
death. C) Proposed model for enterocin CRL35 mechanism of action and immunity under 
physiological conditions. The bacteriocin would bind to IIC and IID subunits of man-PTS system to 
be anchored in the proximity of the cellular membrane. To date, man-PTS is the only receptor 
described for class II bacteriocins (Kjos et al., 2009, 2010). Once anchored, the bacteriocin could 
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form the oligomeric pore as described above. In a bacteriocin producer cell (right), the immunity 
protein would interact with the oligomeric pore forming a receptor-bacteriocin-immunity protein 
complex, as described by Diep et al. (Diep et al., 2007). The immunity protein would directly interact 
with the pore formed by the bacteriocin and indirectly with the receptor to form the ternary complex. 
OM: outer membrane, IM: inner membrane, PG: peptidoglycan, I: immunity protein, R: receptor, 
CW: cell wall, CM: cell membrane. 
 
SUPPLEMENTARY FIGURE LEGENDS 
 
FIGURE 1S. Expression of MunC upon induction with IPTG. Lanes 1) Protein Ladder, 2) 
repressed pACYCDuet-1 (Glucose 0.6%), 3) induced pACYCDuet-1 (0.01 mM IPTG), 4) repressed 
pmunC (Glucose 0.6%), 5) induced pmunC (0.01mM IPTG). Calculated molecular mass for MunC: 
11.05kDa. 
FIGURE 2S. Expression of RR-Ent35. E. coli BL21 transformed with p-etpM-munA and p1707 
were grown in LB until OD600 ~ 0.6. Then the expression of EtpM-Ent35 and RR-Ent35 was induced 
with arabinose 0.6%. The cultures were washed, resuspended in 20 mM Tris-HCl buffer pH 7.4 and 
logarithmic dilutions were made. A) Viable counts and B) 10 µl of each dilution were spotted in LB-
agar plates. Results are representative of four independent replications. Different letters indicate 
significant differences according to Tukey's test, p <0.0001. 
FIGURE 3S: Viability of permeabilized E. coli cells. Viability of permeabilized E. coli MC4100 
after treatment with 50 AU/mL of enterocin CRL35, microcin V, Ent35-MccV or MccV-Ent35, 
respectively. The control was performed without bacteriocin. Data are graphed as percentage of 
viability with respect to the control. Results are representative of four independent replications. 
Different letters indicate significant differences according to Tukey's test, p <0.0001. 
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FIGURE 1. A) Selection of E. coli DH5α EtpM-Ent35 expressing clones. After transformation with the ligation 
mixture containing the plasmid p1707 and etpM49 digested, twenty colonies were plated on LB-glucose 0.6 
% (above) or LB- arabinose 0.6 % (below). The plates were incubated at 37 °C overnight. Control: E. coli 
DH5α (p1707). B) Antimicrobial activity of probe expressing strains. 20 µl of crude extracts obtained after 
induction with arabinose 0.6 % where spotted and tested against of L. innocua 7 (above) and E. coli BL21 
(below). EtpM: E. coli BL21 (p-etpM); EtpM-Ent35: E. coli BL21 (p-etpM-munA); EtpM-Ent35/MunC: E. coli 
BL21 (p-etpM-munA) (pMunC); and RR-EtpM: E. coli BL21 (p1707), respectively.  
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FIGURE 2. Expression and cellular localization of EtpM-Ent35. A) Biological activity revealed by Tris-Tricine 
SDS-PAGE.  Membranes were purified by ultracentrifugation and proteins were separated by electrophoresis. 
Fixed gel was placed on TSB and covered with soft agar inoculated with L. innocua 7. The picture shows the 
zones of growth inhibition by the membrane fraction from arabinose induced cells. Lane 1: EtpM-Ent35 
expressing membranes, lane 2:  EtpM-Ent35/MunC expressing membranes and lane 3: synthetic enterocin 
CRL35 (MM: 4.29 kDa). Calculated molecular mass for EtpM-MunA: 10.35 kDa. B) Subcellular localization of 
EtpM-Ent35 expressed in E. coli BL21. A culture of E. coli BL21 expressing EtpM-Ent35 was harvested, 
washed and permeabilized with EDTA. Then it was split and each half was treated with proteinase K (PK) or 
PMSF plus protease inhibitor cocktail, respectively. Then the different subcellular fractions of each treatment 
were obtained and 10 µl of each one were spotted on TSB agar plate and covered with a L. innocua 7 lawn. 
1) supernatant, 2) periplasm, 3) cytoplasm and 4) membrane.  
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FIGURE 3. Viability of strains expressing EtpM-Ent35 and immunity protein. The strains E. coli BL21 (p-
etpM-munA); E. coli BL21 (p-etpM-munA) (pmunC) and control E. coli BL21 (p-etpM) were grown in LB-
glucose 0.6% until OD600~ 0.6. Then they were harvested, washed and resuspended in LB. A) Logarithmic 
dilutions of each culture were made and 10 µl of each dilution were spotted on plates with glucose 0.6 %, 
arabinose 0.6 % or arabinose 0.6 % + lactose 0.02 %. B and C) Effect of 5 minutes arabinose induction on 
cellular viability. Cultures were induced with lactose during 1 h and then with arabinose 0.6% for 5 minutes. 
Cells were washed and resuspended in 20 mM Tris-HCl buffer pH 7.4. The viability was estimated by CFU/ml 
counting on LB plates. Results are representative of three independent replications. Different letters indicate 
significant differences according to Tukey's test, p <0.0001. D) Quantification by using LIVE/DEAD® 
BacLightTM bacterial viability Kit. Results represent the average of three independent experiments ± 
standard deviations. Different letters indicate significant differences according to Tukey's test, p <0.0001. 
(E) Fluorescence microscopy images of live and dead cells after 5 minutes induction with arabinose as 
described in figure 3B.  
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FIGURE 4. Effect of EtpM-Ent35 in cell membrane electric potential. The expression of the fusion and the 
immunity protein was induced with arabinose 0.6 % and lactose 0.02 %, respectively. DiSC3[5] was added 
at a final concentration of 0.4 µM and fluorescence was registered over time. Excitation and emission 
wavelengths were set at 622 and 667 nm respectively. This data is representative of three separate studies. 
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FIGURE 5. A) Model for expression of EtpM-Ent35 in E. coli. The expression of EtpM-Ent35 fusion peptide 
could result in the insertion of enterocin CRL35 in the membrane of E. coli. EtpM is translocated and inserted 
by YidC (Gérard et al., 2004). Once EtpM is anchored in the membrane; enterocin CRL35 portion may 
penetrate from the periplasm and disrupt the membrane. etpM-munA is under control of the PBAD 
promoter, induced by arabinose and repressed by glucose. OM: outer membrane, IM: inner membrane, PG: 
peptidoglycan.  
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FIGURE 5. B) Model for EtpM-Ent35 and MunC mechanism of action in E. coli. The suicide probe EtpM-Ent35 
is translocated to E. coli periplasm. Then enterocin CRL35 would be inserted in the membrane forming an 
oligomeric pore. The dissipation of the electrochemical gradient and outflow of small organic molecules 
would trigger the cell death. When immunity protein MunC is co-expressed (right panel), it would recognize 
the inserted bacteriocin in the membrane forming a bacteriocin-immunity protein complex preventing cell 
death. C) Proposed model for enterocin CRL35 mechanism of action and immunity under physiological 
conditions. The bacteriocin would bind to IIC and IID subunits of man-PTS system to be anchored in the 
proximity of the cellular membrane. To date, man-PTS is the only receptor described for class II bacteriocins 
(Kjos et al., 2009, 2010). Once anchored, the bacteriocin could form the oligomeric pore as described 
above. In a bacteriocin producer cell (right), the immunity protein would interact with the oligomeric pore 
forming a receptor-bacteriocin-immunity protein complex, as described by Diep et al. (Diep et al., 2007). 
The immunity protein would directly interact with the pore formed by the bacteriocin and indirectly with the 
receptor to form the ternary complex. OM: outer membrane, IM: inner membrane, PG: peptidoglycan, I: 
immunity protein, R: receptor, CW: cell wall, CM: cell membrane.  
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FIGURE 1S. Expression of MunC upon induction with IPTG. Lanes 1) Protein Ladder, 2) repressed 
pACYCDuet-1 (Glucose 0.6%), 3) induced pACYCDuet-1 (0.01 mM IPTG), 4) repressed pmunC (Glucose 
0.6%), 5) induced pmunC (0.01mM IPTG). Calculated molecular mass for MunC: 11.05kDa.  
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FIGURE 2S. Expression of RR-Ent35. E. coli BL21 transformed with p-etpM-munA and p1707 were grown in 
LB until OD600 ~ 0.6. Then the expression of EtpM-Ent35 and RR-Ent35 was induced with arabinose 0.6%. 
The cultures were washed, resuspended in 20 mM Tris-HCl buffer pH 7.4 and logarithmic dilutions were 
made. A) Viable counts and B) 10 µl of each dilution were spotted in LB-agar plates. Results are 
representative of four independent replications. Different letters indicate significant differences according to 
Tukey's test, p <0.0001.  
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FIGURE 3S: Viability of permeabilized E. coli cells. Viability of permeabilized E. coli MC4100 after treatment 
with 50 AU/mL of enterocin CRL35, microcin V, Ent35-MccV or MccV-Ent35, respectively. The control was 
performed without bacteriocin. Data are graphed as percentage of viability with respect to the control. 
Results are representative of four independent replications. Different letters indicate significant differences 
according to Tukey's test, p <0.0001.  
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Escherichia coli cells are naturally insensitive to the bacteriocin enterocin CRL35.  
When the bacteriocin is anchored to the periplasmic face of the plasma membrane through the 
bitopic membrane protein, EtpM, the bacteria depolarize and die and the co-expression of its 
immunity protein prevents the deleterious effect of EtpM-enterocin CRL35.  
The binding and anchoring of the bacteriocin to the membrane has demonstrated to be a 
sufficient condition for its membrane insertion. 
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